At Dana-Farber, your treatment team is based in one of the specialized disease centers for different types of cancers. You may be referred to the Center for Immuno-Oncology to discuss the possibility of participating in a clinical trial. In most cases,
the clinical trials will be for patients who have already received standard treatments, and the CIO team will work closely with your physician at DF/BWCC or referring physician.
The specialists in the CIO will discuss what immunotherapy is and why they think this may be an option for you. The treatments provided in the CIO are clinical trials, and are covered through major insurance.
Center for Immuno-Oncology Specialists
F. Stephen Hodi, MD, Director
Patrick Ott, MD, PhD, Clinical Director
Osama Rahma, MD
Kristina Kelley, RN, BSN, MPH
Rosemarie Baylies, RN, BSN, MHP, OCN
Christine Gillen McKay, RN, BSN
Jennifer Rowan, RN, BSN, OCN
Srinika Ranasinghe, PhD
Administrative Director, Disease Center Operations
Jennifer Riley Foley
Senior Clinical Research Manager